Latest United States Food and Drug Administration Stories
SOUTH PLAINFIELD, N.J., Dec. 23, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
CSL Behring Continues Improving Patient Well-Being; Key Milestone Achieved in PROLONG-9FP, Company's Recombinant Factor IX Fusion Protein Development Program KING OF PRUSSIA,
SAN DIEGO, Dec. 11, 2014 /PRNewswire/ -- Aethlon Medical, Inc.
All Currently Enrolled Patients Can Continue Receiving Aldoxorubicin Therapy or Comparator Drugs; One Inclusion/Exclusion Criteria to be Amended for New Trial Patients to Add Additional Safety Measure
Cap and Trade Policy for Added Sugars Shown a Promising Strategy to Reduce Consumption, Improve Health BOSTON, Nov.
SAN FRANCISCO, Oct.
SAN DIEGO, Oct. 9, 2014 /PRNewswire/ -- Astute Medical, Inc.
NEW YORK and PETACH TIKVAH, Israel, Oct. 7, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.
- To give a box on the ear to.